Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.680
-0.130 (-2.70%)
At close: Apr 1, 2025, 4:00 PM
4.930
+0.250 (5.34%)
After-hours: Apr 1, 2025, 6:31 PM EDT

Radiopharm Theranostics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
36.4418.5811.726.980.03
Cash & Short-Term Investments
36.4418.5811.726.980.03
Cash Growth
1823.88%58.77%-56.64%99486.97%-
Accounts Receivable
4.63-0.10.06-
Other Receivables
1.620.994.3600.01
Receivables
6.250.994.470.060.01
Other Current Assets
-3.290.130.23-
Total Current Assets
44.3522.8516.327.260.03
Property, Plant & Equipment
0.060.060.070-
Other Intangible Assets
4849.0958.5456.08-
Other Long-Term Assets
0.040.040.040.04-
Total Assets
92.4572.0474.9583.380.03
Accounts Payable
3.146.432.961.190.06
Accrued Expenses
4.592.572.111.020.03
Short-Term Debt
----0.06
Other Current Liabilities
2.268.578.165.66-
Total Current Liabilities
13.1517.5813.237.880.16
Other Long-Term Liabilities
27.327.1116.1412.54-
Total Liabilities
40.4544.6829.3720.420.16
Common Stock
168.28100.6897.2386.760
Retained Earnings
-127.79-111.34-65.35-30.91-0.49
Comprehensive Income & Other
12.7138.7812.517.110.36
Total Common Equity
53.228.1244.3862.96-0.12
Minority Interest
-1.2-0.771.19--
Shareholders' Equity
5227.3545.5862.96-0.12
Total Liabilities & Equity
92.4572.0474.9583.380.03
Total Debt
----0.06
Net Cash (Debt)
36.4418.5811.726.98-0.03
Net Cash Growth
1823.88%58.77%-56.64%--
Net Cash Per Share
0.030.050.040.15-
Filing Date Shares Outstanding
2,2012,173339.31255.43100
Total Common Shares Outstanding
2,201460.37339.31255.43100
Working Capital
31.215.273.0719.39-0.12
Book Value Per Share
0.020.060.130.25-0.00
Tangible Book Value
5.2-20.96-14.166.89-0.12
Tangible Book Value Per Share
0.00-0.05-0.040.03-0.00
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q